FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Krista Lanctôt

Research Profile

Disorders

Concepts & Ideas

Procedures

Double-Blind Method

Chemicals & Drugs

Activities & Behaviors

Aggression

Co-author Network

Publications

TOP 3
Walter Swardfager; Graham Mazereeuw; Roger S McIntyre; Yael Schwartz; Danielle S Cha; Kyle Goldberger; Nathan Herrmann; Krista L Lanctôt
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder.
Lea T Drye; Nathan Herrmann; Krista L Lanctôt; Jacobo E Mintzer; Paul B Rosenberg; Roberta W Scherer; David Bachman
Designing a Trial to Evaluate Potential Treatments for Apathy in Dementia: The Apathy in Dementia Methylphenidate Trial (ADMET).
Anna H Noel-Storr; Craig W Ritchie; Danielle Fraser Solomon; Frans R Verhey; Josephine Walton; Phillip Wood; Rosemary Worrall; Gillian E Mead; Emma Molena; Giang Huong Nguyen; Prateek Choudhary; Linda Clare; Meera Desai; Mario Fioravanti; Leon Flicker; Tarun Gupta; Anja Hayen; Chris Hyde; Emma Ladds; Krista L Lanctôt; Sue Marcus; Jenny M McCleery; Rupert McShane
Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Krista Lanctôt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Walter Swardfager; Graham Mazereeuw; Roger S McIntyre; Yael Schwartz; Danielle S Cha; Kyle Goldberger; Nathan Herrmann; Krista L Lanctôt
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder.
Neuroscience and biobehavioral reviews 2013;37(5):911-29.
2013: Lea T Drye; Nathan Herrmann; Krista L Lanctôt; Jacobo E Mintzer; Paul B Rosenberg; Roberta W Scherer; David Bachman
Designing a Trial to Evaluate Potential Treatments for Apathy in Dementia: The Apathy in Dementia Methylphenidate Trial (ADMET).
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2013;21(6):549-59.
2013: Anna H Noel-Storr; Craig W Ritchie; Danielle Fraser Solomon; Frans R Verhey; Josephine Walton; Phillip Wood; Rosemary Worrall; Gillian E Mead; Emma Molena; Giang Huong Nguyen; Prateek Choudhary; Linda Clare; Meera Desai; Mario Fioravanti; Leon Flicker; Tarun Gupta; Anja Hayen; Chris Hyde; Emma Ladds; Krista L Lanctôt; Sue Marcus; Jenny M McCleery; Rupert McShane
Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2013;9(3):e96-e105.
2013: Walter Swardfager; Daniel A Winer; Shawn Winer; Nathan Herrmann; Krista L Lanctôt
Interleukin-17 in post-stroke neurodegeneration.
Neuroscience and biobehavioral reviews 2013;37(3):436-47.
2013: Mahwesh Saleem; Prathiba Shammi; Walter Swardfager; Stan Van Uum; Nathan Herrmann; Alexander Kiss; Gideon Koren; Paul I Oh; Krista L Lanctôt
Higher cortisol predicts less improvement in verbal memory performance after cardiac rehabilitation in patients with coronary artery disease.
Cardiovascular psychiatry and neurology 2013;2013():340342.
2013: J M Hussman; Krista L Lanctôt; B Paes
The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence.
Journal of medical economics 2013;16(1):115-24.
2012: Julia M Hussman; Abby Li; Bosco Paes; Krista L Lanctôt
A review of cost-effectiveness of palivizumab for respiratory syncytial virus.
Expert review of pharmacoeconomics & outcomes research 2012;12(5):553-67.
2012: Nathan Herrmann; Sandra E Black; Jaclyn Cappell; Tiffany Chow; David F Tang-Wai; Krista L Lanctôt
Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2012;20(9):789-97.
2012: Graham Mazereeuw; Walter Swardfager; Sarah A Chau; Krista L Lanctôt; Nathan Herrmann
Effects of omega-3 fatty acids on cognitive performance: a meta-analysis.
Neurobiology of aging 2012;33(7):1482.e17-29.
2012: Walter Swardfager; Stephen Cornish; Nathan Herrmann; Susan Marzolini; Graham Mazereeuw; Lauren Sham; Krista L Lanctôt
Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis.
American heart journal 2012;163(4):666-76.e1-3.
2012: Karen Levy; Abby Li; Shale B Farber; Krista L Lanctôt; Nathan Herrmann
Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?
Drugs & aging 2012;29(3):167-79.
2012: Mark Sinyor; Kelly A Smart; Krista L Lanctôt; Anthony J Levitt; Ayal Schaffer; Noam H Grysman
Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
The Journal of clinical psychiatry 2012;73(2):e277-87.
2011: Nathan Herrmann; Ida Kircanski; Sarah A Chau; Krista L Lanctôt
Current and emerging drug treatment options for Alzheimer's disease: a systematic review.
Drugs 2011;71(15):2031-65.
2011: Robert A Mitchell; Nathan Herrmann; Krista L Lanctôt
The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease.
CNS neuroscience & therapeutics 2011;17(5):411-27.
2011: Walter Swardfager; Jaclyn Cappell; Nathan Herrmann; Alexander Kiss; Susan Marzolini; Paul I Oh; Mahwesh Saleem; Prathiba Shammi; Krista L Lanctôt
Verbal memory performance and completion of cardiac rehabilitation in patients with coronary artery disease.
Psychosomatic medicine 2011;73(7):580-7.
2011: Tanya Pinto; Krista L Lanctôt; Nathan Herrmann
Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type.
Ageing research reviews 2011;10(4):404-12.
2011: Walter Swardfager; Susan Marzolini; Paul I Oh; Mahwesh Saleem; Shale B Farber; Nathan Herrmann; Alexander Kiss; Krista L Lanctôt
Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease.
The Journal of clinical psychiatry 2011;72(9):1181-8.
2011: W Swardfager; P R Albert; M Daigle; N Herrmann; A Kiss; S Marzolini; P I Oh; M Saleem; P Shammi; Krista L Lanctôt
Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease.
Brain, behavior, and immunity 2011;25(6):1264-71.
2011: Ian Mitchell; Bosco A Paes; Krista L Lanctôt; Abby Li
CARESS: the Canadian registry of palivizumab.
The Pediatric infectious disease journal 2011;30(8):651-5.
2011: Kelly A Smart; Nathan Herrmann; Krista L Lanctôt
Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes research.
Journal of geriatric psychiatry and neurology 2011;24(2):67-72.
2011: Nathan Herrmann; Jaclyn Cappell; Goran M Eryavec; Krista L Lanctôt
Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study.
CNS drugs 2011;25(5):425-33.
2011: Nathan Herrmann; Sandra E Black; Abby Li; Krista L Lanctôt
Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts.
International psychogeriatrics / IPA 2011;23(4):539-45.
2011: Nathan Herrmann; Abby Li; Krista L Lanctôt
Memantine in dementia: a review of the current evidence.
Expert opinion on pharmacotherapy 2011;12(5):787-800.
2011: Allison B Gold; Nathan Herrmann; Walter Swardfager; Sandra E Black; Richard I Aviv; Gayla Tennen; Alexander Kiss; Krista L Lanctôt
The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment.
Journal of neuroinflammation 2011;8():17.
2011: Sandy G Grupp; Mark L Greenberg; Joel G Ray; Usoa Busto; Krista L Lanctôt; Irena Nulman; Gideon Koren
Pediatric cancer rates after universal folic acid flour fortification in Ontario.
Journal of clinical pharmacology 2011;51(1):60-5.
2010: Nathan Herrmann; Derrick Y Tam; Robert Balshaw; Robert Sambrook; Nadia Lesnikova; Krista L Lanctôt
The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2010;55(12):768-75.
2010: Walter Swardfager; Krista L Lanctôt; Lana Rothenburg; Amy Wong; Jaclyn Cappell; Nathan Herrmann
A meta-analysis of cytokines in Alzheimer's disease.
Biological psychiatry 2010;68(10):930-41.
2010: Jaclyn Cappell; Nathan Herrmann; Stephen Cornish; Krista L Lanctôt
The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease.
CNS drugs 2010;24(11):909-27.
2010: Kelly A Smart; Krista L Lanctôt; Bosco A Paes
Rebuttal: palivizumab for the prevention of respiratory syncytial virus infection.
Canadian family physician Médecin de famille canadien 2010;56(10):988-91.
2010: Lana S Rothenburg; Nathan Herrmann; Walter Swardfager; Sandra E Black; Gayla Tennen; Alexander Kiss; David J Gladstone; Jon Ween; Abraham Snaiderman; Krista L Lanctôt
The relationship between inflammatory markers and post stroke cognitive impairment.
Journal of geriatric psychiatry and neurology 2010;23(3):199-205.
2010: Mark J Rapoport; Robert A Mitchell; Scott McCullagh; Nathan Herrmann; Florance Chan; Alex Kiss; Anthony Feinstein; Krista L Lanctôt
A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.
The Journal of clinical psychiatry 2010;71(9):1125-30.
2010: Walter Swardfager; Nathan Herrmann; Susan Marzolini; Mahwesh Saleem; Alexander Kiss; Prathiba Shammi; Paul I Oh; Krista L Lanctôt
Cardiopulmonary fitness is associated with cognitive performance in patients with coronary artery disease.
Journal of the American Geriatrics Society 2010;58(8):1519-25.
2010: Mark Sinyor; Anthony J Levitt; Amy H Cheung; Ayal Schaffer; Alex Kiss; Yekta Dowlati; Krista L Lanctôt
Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
The Journal of clinical psychiatry 2010;71(3):270-9.
2010: Yekta Dowlati; Nathan Herrmann; Walter Swardfager; Helena Liu; Lauren Sham; Elyse K Reim; Krista L Lanctôt
A meta-analysis of cytokines in major depression.
Biological psychiatry 2010;67(5):446-57.
2010: Yekta Dowlati; Nathan Herrmann; Walter L Swardfager; Elyse K Reim; Krista L Lanctôt
Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2010;55(2):91-9.
2010: Kelly A Smart; Bosco A Paes; Krista L Lanctôt
Changing costs and the impact on RSV prophylaxis.
Journal of medical economics 2010;13(4):705-8.
2010: Yekta Dowlati; Nathan Herrmann; Walter Swardfager; Steven Thomson; Paul I Oh; Stan Van Uum; Gideon Koren; Krista L Lanctôt
Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease.
Neuropsychiatric disease and treatment 2010;6():393-400.
2009: Krista L Lanctôt; Ryan D Rajaram; Nathan Herrmann
Therapy for Alzheimer's Disease: How Effective are Current Treatments?
Therapeutic advances in neurological disorders 2009;2(3):163-80.
2009: Mark J Rapoport; Krista L Lanctôt; David Streiner; Michel Bédard; Evelyn Vingilis; Brian Murray; Ayal Schaffer; Kenneth I Shulman; Nathan Herrmann
Benzodiazepine use and driving: a meta-analysis.
The Journal of clinical psychiatry 2009;70(5):663-73.
2009: Nathan Herrmann; Mark J Rapoport; Ryan D Rajaram; Florance Chan; Alex Kiss; Andrew K Ma; Anthony Feinstein; Scott McCullagh; Krista L Lanctôt
Factor analysis of the Rivermead Post-Concussion Symptoms Questionnaire in mild-to-moderate traumatic brain injury patients.
The Journal of neuropsychiatry and clinical neurosciences 2009;21(2):181-8.
2008: Pearl Behl; Krista L Lanctôt; David Streiner; Sandra Black
The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort.
International psychogeriatrics / IPA 2008;20(6):1141-59.
2008: Krista L Lanctôt; Shababa T Masoud; Bosco A Paes; Jean-Eric Tarride; Aaron Chiu; Charles Hui; Philip L Francis; Paul I Oh
The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis .
Current medical research and opinion 2008;24(11):3223-37.
2008: Zahinoor Ismail; Nathan Herrmann; Lana S Rothenburg; Adolfo Cotter; Farrell Leibovitch; Shahryar Rafi-Tari; Sandra Black; Krista L Lanctôt
A functional neuroimaging study of appetite loss in Alzheimer's disease.
Journal of the neurological sciences 2008;271(1-2):97-103.
2008: Krista L Lanctôt; Nathan Herrmann; Lana S Rothenburg
Commentary: Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels.
Experimental neurology 2008;212(2):251-4.
2008: Krista L Lanctôt; Nathan Herrmann; Sandra Black; Michelle Ryan; Lana S Rothenburg; Barbara A Liu; Usoa E Busto
Apathy associated with Alzheimer disease: use of dextroamphetamine challenge.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(7):551-7.
2008: Nathan Herrmann; Lana S Rothenburg; Sandra Black; Michelle Ryan; Barbara A Liu; Usoa E Busto; Krista L Lanctôt
Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
Journal of clinical psychopharmacology 2008;28(3):296-301.
2008: Florance Chan; Krista L Lanctôt; Anthony Feinstein; Nathan Herrmann; John Strauss; Tricia Sicard; James L Kennedy; Scott McCullagh; Mark J Rapoport
The serotonin transporter polymorphisms and major depression following traumatic brain injury.
Brain injury : [BI] 2008;22(6):471-9.
2008: Walter Swardfager; Nathan Herrmann; Yekta Dowlati; Paul I Oh; Alex Kiss; Krista L Lanctôt
Relationship between cardiopulmonary fitness and depressive symptoms in cardiac rehabilitation patients with coronary artery disease.
Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine 2008;40(3):213-8.
2007: Krista L Lanctôt; Nathan Herrmann; Hooman Ganjavi; Sandra Black; Pablo Rusjan; Sylvain Houle; Alan Wilson
Serotonin-1A receptors in frontotemporal dementia compared with controls.
Psychiatry research 2007;156(3):247-50.
2007: Nathan Herrmann; Krista L Lanctôt
Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2007;52(10):630-46.
2007: Krista L Lanctôt; Doug F Hussey; Nathan Herrmann; Sandra Black; Pablo Rusjan; Alan Wilson; Sylvain Houle; Nicole Kozloff; Nicolaas P L G Verhoeff; Shitij Kapur
A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2007;15(10):888-98.
2007: Krista L Lanctôt; Nathan Herrmann
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cholinesterase inhibitors in Alzheimer's disease--evidence-based or evidence-biased?
Alzheimer's & dementia : the journal of the Alzheimer's Association 2007;3(3):177-9.
2007: Sarah Thompson; Nathan Herrmann; Mark J Rapoport; Krista L Lanctôt
Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2007;52(4):248-55.
2007: Krista L Lanctôt; Nathan Herrmann; Lana Rothenburg; Goran Eryavec
Behavioral correlates of GABAergic disruption in Alzheimer's disease.
International psychogeriatrics / IPA 2007;19(1):151-8.
2007: Krista L Lanctôt; Shehnaz Moosa; Nathan Herrmann; Farrell Leibovitch; Lana Rothenburg; Adolfo Cotter; Sandra Black
A SPECT study of apathy in Alzheimer's disease.
Dementia and geriatric cognitive disorders 2007;24(1):65-72.
2007: Hooman Ganjavi; Nathan Herrmann; Paula A Rochon; Papita Sharma; Monica Lee; Daniel Cassel; Morris Freedman; Sandra Black; Krista L Lanctôt
Adverse drug events in cognitively impaired elderly patients.
Dementia and geriatric cognitive disorders 2007;23(6):395-400.
2007: Nathan Herrmann; Krista L Lanctôt; Lana Rothenburg; Goran Eryavec
A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
Dementia and geriatric cognitive disorders 2007;23(2):116-9.
2006: Nathan Herrmann; Krista L Lanctôt; Robert Sambrook; Nadia Lesnikova; Réjean Hébert; Peter McCracken; Alain Robillard; Elizabeth Nguyen
The contribution of neuropsychiatric symptoms to the cost of dementia care.
International journal of geriatric psychiatry 2006;21(10):972-6.
2006: Papita Sharma; Nathan Herrmann; Paula A Rochon; Monica Lee; Ruth Croxford; Lana Rothenburg; Sandra Black; Krista L Lanctôt
Perceptions of natural health products among patients attending a memory clinic.
American journal of Alzheimer's disease and other dementias 2006;21(3):156-63.
2006: Pearl Behl; Krista L Lanctôt; David Streiner; I Guimont; Sandra Black
Cholinesterase inhibitors slow decline in executive functions, rather than memory, in Alzheimer's disease: a 1-year observational study in the Sunnybrook dementia cohort.
Current Alzheimer research 2006;3(2):147-56.
2006: Nathan Herrmann; Krista L Lanctôt
Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?
Drug safety : an international journal of medical toxicology and drug experience 2006;29(10):833-43.
2005: Jennifer M Glass; Krista L Lanctôt; Nathan Herrmann; Beth A Sproule; Usoa E Busto
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits.
BMJ (Clinical research ed.) 2005;331(7526):1169.
2005: Michiel Hemels; Adrienne Einarson; Gideon Koren; Krista L Lanctôt; Thomas R Einarson
Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis.
The Annals of pharmacotherapy 2005;39(5):803-9.
2005: Krista L Lanctôt; Nathan Herrmann
Review: donepezil improves cognitive and global function in people with mild to moderate Alzheimer's disease.
Evidence-based mental health 2005;8(1):15.
2005: Nathan Herrmann; Krista L Lanctôt
Do atypical antipsychotics cause stroke?
CNS drugs 2005;19(2):91-103.
2004: Krista L Lanctôt; Nathan Herrmann; Neelesh K Nadkarni; Farrell Leibovitch; Curtis B Caldwell; Sandra Black
Medial temporal hypoperfusion and aggression in Alzheimer disease.
Archives of neurology 2004;61(11):1731-7.
2004: Nathan Herrmann; Krista L Lanctôt; Goran Eryavec; Robert van Reekum; Lyla R Khan
Growth hormone response to clonidine predicts aggression in Alzheimer's disease.
Psychoneuroendocrinology 2004;29(9):1192-7.
2004: Sarah Thompson; Krista L Lanctôt; Nathan Herrmann
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
Expert opinion on drug safety 2004;3(5):425-40.
2004: Krista L Lanctôt; Nathan Herrmann; Paolo Mazzotta; Lyla R Khan; Neil Ingber
GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2004;49(7):439-53.
2004: Nathan Herrmann; Krista L Lanctôt; Goran Eryavec; Lyla R Khan
Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients.
Journal of psychopharmacology (Oxford, England) 2004;18(2):215-20.
2004: Nathan Herrmann; Muhammad Mamdani; Krista L Lanctôt
Atypical antipsychotics and risk of cerebrovascular accidents.
The American journal of psychiatry 2004;161(6):1113-5.
2004: Nathan Herrmann; Krista L Lanctôt; Lyla R Khan
The role of norepinephrine in the behavioral and psychological symptoms of dementia.
The Journal of neuropsychiatry and clinical neurosciences 2004;16(3):261-76.
2003: Krista L Lanctôt; Nathan Herrmann; Kenneth K Yau; Lyla R Khan; Barbara A Liu; Maysoon M LouLou; Thomas R Einarson
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;169(6):557-64.
2003: Grace Wu; Krista L Lanctôt; Nathan Herrmann; Shehnaz Moosa; Paul I Oh
The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.
CNS drugs 2003;17(14):1045-57.
2003: Krista L Lanctôt; Nathan Herrmann; Maysoon M LouLou
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.
Journal of psychiatry & neuroscience : JPN 2003;28(1):13-26.
2002: Krista L Lanctôt; Nathan Herrmann; Goran Eryavec; Robert van Reekum; Kenton Reed; Claudio A Naranjo
Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(4):646-54.
2002: Fran L Paradiso-Hardy; John Papastergiou; Krista L Lanctôt; Eric A Cohen
Thrombotic thrombocytopenic purpura associated with clopidogrel: further evaluation.
The Canadian journal of cardiology 2002;18(7):771-3.
2002: Krista L Lanctôt; Nathan Herrmann; Robert van Reekum; Goran Eryavec; Claudio A Naranjo
Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease.
International journal of geriatric psychiatry 2002;17(6):531-41.
2002: Julie M Dergal; Jennifer L Gold; Dara Laxer; Monica S W Lee; Malcolm A Binns; Krista L Lanctôt; Morris Freedman; Paula A Rochon
Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic.
Drugs & aging 2002;19(11):879-86.
2001: P I Oh; Michael Iskedjian; Antonio Addis; Krista L Lanctôt; T R Einarson
Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 2001;8(4):199-206.
2001: Michiel Hemels; Krista L Lanctôt; Michael Iskedjian; Thomas R Einarson
Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.
Drugs & aging 2001;18(7):527-50.
2001: Krista L Lanctôt; Nathan Herrmann; Paolo Mazzotta
Role of serotonin in the behavioral and psychological symptoms of dementia.
The Journal of neuropsychiatry and clinical neurosciences 2001;13(1):5-21.
2001: Jennifer L Gold; Dara Laxer; Julie M Dergal; Krista L Lanctôt; Paula A Rochon
Herbal-drug therapy interactions: a focus on dementia.
Current opinion in clinical nutrition and metabolic care 2001;4(1):29-34.
2000: Fran L Paradiso-Hardy; C M Angelo; Krista L Lanctôt; Eric A Cohen
Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000;163(11):1441-8.
2000: Claudio A Naranjo; J Fourie; N Herrmann; Krista L Lanctôt; C Birt; Kenneth K Yau
Probing peripheral and central cholinergic system responses.
Journal of psychiatry & neuroscience : JPN 2000;25(4):325-36.
2000: Krista L Lanctôt; Nathan Herrmann
Donepezil for behavioural disorders associated with Lewy bodies: a case series.
International journal of geriatric psychiatry 2000;15(4):338-45.
2000: Nathan Herrmann; Krista L Lanctôt; M Myszak
Effectiveness of gabapentin for the treatment of behavioral disorders in dementia.
Journal of clinical psychopharmacology 2000;20(1):90-3.
1998: Krista L Lanctôt; T S Best; Nicole Mittmann; Barbara A Liu; Paul I Oh; Thomas R Einarson; Claudio A Naranjo
Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.
The Journal of clinical psychiatry 1998;59(10):550-61; quiz 562-3.
1998: J H Moss; Krista L Lanctôt
Iatrogenic benzodiazepine withdrawal delirium in hospitalized older patients.
Journal of the American Geriatrics Society 1998;46(8):1020-2.
1997: Michael Iskedjian; K Trakas; CA Bradley; Antonio Addis; Krista L Lanctôt; D Kruk; A Lane Ilersich; Thomas R Einarson
Quality assessment of economic evaluations published in PharmacoEconomics. The first four years (1992 to 1995).
PharmacoEconomics 1997;12(6):685-94.
1997: Nicole Mittmann; Nathan Herrmann; Thomas R Einarson; Usoa E Busto; Krista L Lanctôt; Barbara A Liu; Kenneth I Shulman; Ivan Silver; C A Narango; Neil H Shear
The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.
Journal of affective disorders 1997;46(3):191-217.
1997: Nathan Herrmann; Krista L Lanctôt
From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1997;42 Suppl 1():51S-64S.
1995: Krista L Lanctôt; Claudio A Naranjo
Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events.
Clinical pharmacology and therapeutics 1995;58(6):692-8.
1995: CA Bradley; Michael Iskedjian; Krista L Lanctôt; Nicole Mittmann; C Simone; E St Pierre; E Miller; B Blatman; B Chabursky; Thomas R Einarson
Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals.
The Annals of pharmacotherapy 1995;29(7-8):681-9.
1995: Claudio A Naranjo; C X Poulos; Krista L Lanctôt; Karen E Bremner; M Kwok; M Umana
Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects.
Addiction (Abingdon, England) 1995;90(7):893-905.
1995: Claudio A Naranjo; Karen E Bremner; Krista L Lanctôt
Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems.
Addiction (Abingdon, England) 1995;90(1):87-99.
1994: Krista L Lanctôt; B M Ghajar; Neil H Shear; Claudio A Naranjo
Improving the diagnosis of hypersensitivity reactions associated with sulfonamides.
Journal of clinical pharmacology 1994;34(12):1228-33.
1994: Claudio A Naranjo; M C Kwok; Krista L Lanctôt; H P Zhao; S P Spielberg; Neil H Shear
Enhanced differential diagnosis of anticonvulsant hypersensitivity reactions by an integrated Bayesian and biochemical approach.
Clinical pharmacology and therapeutics 1994;56(5):564-75.
1994: Krista L Lanctôt; Claudio A Naranjo
Computer-assisted evaluation of adverse events using a Bayesian approach.
Journal of clinical pharmacology 1994;34(2):142-7.
1992: Claudio A Naranjo; Neil H Shear; Krista L Lanctôt
Advances in the diagnosis of adverse drug reactions.
Journal of clinical pharmacology 1992;32(10):897-904.
1992: Claudio A Naranjo; C X Poulos; Karen E Bremner; Krista L Lanctôt
Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers.
Clinical pharmacology and therapeutics 1992;51(6):729-39.
1991: Claudio A Naranjo; Krista L Lanctôt
Recent developments in computer-assisted diagnosis of putative adverse drug reactions.
Drug safety : an international journal of medical toxicology and drug experience 1991;6(5):315-22.
1990: Claudio A Naranjo; Krista L Lanctôt; D A Lane
The Bayesian differential diagnosis of neutropenia associated with antiarrhythmic agents.
Journal of clinical pharmacology 1990;30(12):1120-7.
1990: Claudio A Naranjo; D Lane; M Ho-Asjoe; Krista L Lanctôt
A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barré syndrome and zimeldine.
Journal of clinical pharmacology 1990;30(2):174-80.
1989: B M Ghajar; Krista L Lanctôt; Neil H Shear; Claudio A Naranjo
Bayesian differential diagnosis of a cutaneous reaction associated with the administration of sulfonamides.
Seminars in dermatology 1989;8(3):213-8.